Joint Replacements and Weight Loss Drugs (Ozempic, Wegovy, Mounjaro)

GLP-1 receptor agonist medications – including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) – have transformed weight management for many patients. As a knee surgeon, I am increasingly seeing patients who are taking these drugs and wondering how they affect their knee problems, whether they might avoid surgery, or what to consider if they are already planning a total knee replacement or partial knee replacement.

How Does Weight Affect the Knee Joint?

The knee bears significant load during everyday activities. Walking generates forces of roughly two to three times body weight across the joint, and this increases further with stairs, slopes, and impact exercise. In patients with osteoarthritis, this mechanical loading accelerates cartilage wear and contributes to pain, stiffness, and functional limitation.

There is also an inflammatory component. Excess adipose (fat) tissue produces low-grade systemic inflammation through cytokines and adipokines, which can worsen joint pain and cartilage breakdown independently of the mechanical load. Effective weight loss addresses both of these pathways.

What Are GLP-1 Weight Loss Drugs?

GLP-1 receptor agonists were originally developed for type 2 diabetes. They work by mimicking a gut hormone (glucagon-like peptide-1) that regulates appetite and blood sugar. At higher doses, they produce significant weight loss – clinical trials have reported average reductions of 15–20% of body weight with semaglutide and tirzepatide. These medications are administered as weekly injections and are now widely prescribed for weight management.

Can Weight Loss Drugs Help Knee Symptoms?

Meaningful weight loss – even 5–10% of body weight – can reduce knee pain and improve function in patients with osteoarthritis. Some patients who lose substantial weight find their symptoms improve enough to delay or reconsider joint replacement surgery. For patients with early or moderate arthritis, this can be a valuable part of a broader treatment strategy alongside physiotherapy, activity modification, and, where appropriate, injection therapy.

However, weight loss does not reverse structural joint damage. If the articular cartilage is significantly worn, or if there is bone-on-bone change on imaging, reducing body weight will reduce the forces across the joint but may not eliminate pain. A clinical assessment is the best way to understand whether weight loss alone is likely to be sufficient or whether surgical options should also be considered.

Should I Lose Weight Before a Knee Replacement?

In general, achieving a healthier weight before surgery is beneficial. Evidence consistently shows that patients with a lower BMI at the time of knee replacement tend to have fewer wound complications, lower infection rates, shorter hospital stays, and better early functional outcomes. Many surgeons – including the national commissioning guidance in England – recommend optimising weight before proceeding with elective joint replacement where it is safe and realistic to do so.

That said, there is a balance to be struck. Delaying surgery indefinitely while waiting for weight loss can mean living with significant pain and reduced mobility for longer, which has its own consequences for physical and mental health. The decision should be individualised, weighing the potential benefits of preoperative weight loss against the impact of ongoing symptoms.

Perioperative Considerations with GLP-1 Drugs

There are specific practical considerations for patients taking GLP-1 receptor agonists who are planning surgery:

  • Gastric emptying. GLP-1 drugs slow stomach emptying (gastroparesis). This matters for general anaesthesia because it increases the risk of aspiration – stomach contents entering the lungs during intubation. Most current anaesthetic guidelines recommend stopping GLP-1 medications before elective surgery. The exact timing varies by drug and dosing schedule, but a period of one to three weeks before surgery is commonly advised.
  • Nausea and dehydration. GLP-1 drugs can cause nausea, reduced appetite, and occasionally vomiting. Adequate nutrition and hydration before surgery are important for wound healing, immune function, and recovery. Patients should ensure they are eating and drinking well in the weeks around surgery.
  • Muscle mass. Rapid weight loss – whether from medication, dieting, or bariatric surgery – does not only reduce fat. A proportion of the weight lost is lean muscle mass. Lower muscle mass and strength around the knee can affect rehabilitation and early recovery after knee replacement. Maintaining a strength and exercise programme during weight loss is strongly recommended.
  • Blood sugar control. For patients with diabetes, stopping GLP-1 medications before surgery requires a plan for alternative blood sugar management during the perioperative period. This should be coordinated with the anaesthetic and medical teams.

What I Recommend to My Patients

There is no one-size-fits-all answer. My general approach is:

  • If your knee symptoms are manageable and your arthritis is not end-stage, meaningful weight loss – however achieved – is a worthwhile first step and may improve symptoms significantly.
  • If your arthritis is advanced and symptoms are significantly affecting your quality of life, delaying surgery purely for weight loss may not be in your best interest. We can discuss the balance of risks and benefits.
  • If you are taking a GLP-1 medication and planning surgery, we will coordinate with the anaesthetic team on timing for stopping and restarting the drug.
  • Regardless of weight, a structured physiotherapy and strengthening programme before and after surgery (“prehabilitation”) improves outcomes.

The Evolving Evidence

GLP-1 receptor agonists are a relatively recent development in routine clinical use for weight management. The long-term data on how they interact with orthopaedic surgery, implant longevity, and post-surgical rehabilitation are still emerging. As more evidence becomes available, guidelines and recommendations will continue to be refined. I stay up to date with this literature and will tailor advice to each patient’s individual circumstances.

If you are considering knee replacement and are taking or thinking about taking weight loss medication, I am happy to discuss how this fits into your overall treatment plan during a consultation.

This article is for general information only and does not replace individual medical advice. If you have specific questions about your knee problem or medication, please get in touch to arrange a consultation.

← Back to Research, Guidelines & Articles